Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag

In the last years, the use of thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, has improved the management of immune thrombocytopenia (ITP). Moreover, eltrombopag is also active in patients with aplastic anemia and myelodysplastic syndrome. However, their mechanisms of action...

Full description

Bibliographic Details
Main Authors: Jesús María Hernández-Sánchez, José María Bastida, Diego Alonso-López, Rocío Benito, José Ramón González-Porras, Javier De Las Rivas, Jesús María Hernández Rivas, Ana Eugenia Rodríguez-Vicente
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2019.1702156